Pacifico, Corazon .
HRN: 26-68-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/26/2025
03/04/2025
IV
475 Mg
Q 48 Hrs
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes